ClinicalTrials.gg
RecruitingNCT07907952tSCScwRTUpdated Oct 30, 2026

tSCS Combined With Rehabilitation Training in Treating Paraplegic Patients After SCI

An interventional study of Transcutaneous Spinal Cord Stimulation Combined with Rehabilitation Training in Spinal Cord Injury and Paraplegia, Spinal, sponsored by Beijing Tsinghua Chang Gung Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by Beijing Tsinghua Chang Gung Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 10 months after the study started (first participant enrolled Dec 2024, registered Oct 2026).
  • Started Dec 2024; still recruiting 1 year 11 months later.
Updated Oct 30, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This clinical trial aims to evaluate the safety and efficacy of transcutaneous spinal cord stimulation (tSCS) combined with rehabilitation training for treating paraplegia after spinal cord injury (SCI). Previous studies have shown that applying tSCS in the thoracolumbar region can enable patients with complete and incomplete SCI to immediately restore partial voluntary movement, but there are currently no domestic reports on the treatment of SCI paraplegia using tSCS combined with rehabilitation training. The main questions this study aims to answer include: 1. Compared with using tSCS alone, does combined rehabilitation therapy enable patients to better restore voluntary movement? 2. Will this treatment protocol result in fewer adverse events? 3. Can the tSCS combined with rehabilitation training protocol be applied to a large number of patients with paraplegia after SCI to help them restore voluntary movement?For paraplegic patients with SCI (spinal cord injury) whose injury duration exceeds 1 week, baseline data (pre-stimulation, at the end of the first week of stimulation, and post-experiment) need to be collected after assessment. After adjusting the stimulation parameters of tSCS (transcutaneous spinal cord stimulation) and modifying the rehabilitation training plan, a one-month personalized rehabilitation training program will be conducted, followed by at least four weeks of follow-up. Researchers will compare the assessment results recorded at different stages and use specific indicators to evaluate the safety and effectiveness of this treatment protocol.

02

Conditions studied

  • Spinal Cord Injury
  • Paraplegia, Spinal

Keywords

  • Transcutaneous Spinal Cord Stimulation
  • Rehabilitation Training
  • Spinal Cord Injury
  • paraplegia
03

In context

Spinal Cord Injuries

2,025 studies on the registry are indexed under Spinal Cord Injuries; 537 are open to participants now.

This study's planned enrollment of 10 is below the median of 24 across 1,633 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

Beijing Tsinghua Chang Gung Hospital is the lead sponsor of 108 studies on the registry; 56 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 60 years old;
  • Spinal cord injury classified as AIS Grade A, B, C, or D, with the distance between the injury level and the conus medullaris at least 60mm
  • Able to cooperate with rehabilitation training;
  • Stable and healthy physiological condition, as determined by the researcher; must be able to complete the entire study period and cooperate with rehabilitation training.

Exclusion criteria

Exclusion Criteria:

  • 1. Obvious mental disorders (anxiety, depression, etc.) resulting in inability to complete relevant subjective assessments2. Presence of mental or cognitive impairments preventing participation in transcutaneous spinal electrical stimulation and follow-up3. Severe autonomic reflex disorders4. Severe muscle atrophy or joint contractures5. less than 1 year6. Progressive spinal instability or severe spinal deformities7. Uncontrolled hypertension, severe heart disease, or serious medical/respiratory conditions8. Severe hydronephrosis or renal dysfunction9. Individuals considered unsuitable by the researcher
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Transcutaneous Spinal Cord Stimulation Combined with Rehabilitation Training

    Other: Transcutaneous Spinal Cord Stimulation Combined with Rehabilitation Training

Interventions

  • OtherTranscutaneous Spinal Cord Stimulation Combined with Rehabilitation Training

    For paraplegic patients with SCI (spinal cord injury) whose injury duration exceeds 1 week, baseline data (pre-stimulation, at the end of week 1 of stimulation, and post-experiment) need to be collected after assessment. After adjusting the stimulation parameters of tSCS (transcutaneous spinal cord stimulation) and modifying the rehabilitation training plan, a one-month personalized rehabilitation training program will be conducted, followed by at least four weeks of follow-up.

06

What researchers measure

Primary outcomes

  1. Walking Index for Spinal Cord Injury, WISCI Ⅱ

    The commonly used ordinal scale in clinical trials to measure walking ability in patients with spinal cord injury. Based on the severity of walking impairment, the walking function is divided into 21 levels (from level 0, where patients cannot stand or walk, to level 20, where patients can walk at least 10 meters without facilities or assistance) based on the equipment, braces, and assistance required for patients to walk 10 meters.

    Time frame: Baseline、Week 1 of Stimulation and Completion of experiment

  2. 10-Meter Walk Test, 10MWT

    Walking speed test: measures the time required for patients to walk 10 meters, used to assess their short-distance walking ability.

    Time frame: Baseline、Week 1 of Stimulation and Completion of experiment

  3. Weight Bearing Capacity, WBC

    It is a crucial outcome that requires monitoring, especially for patients with severe motor disorders who are unable to walk independently.

    Time frame: Baseline、Week 1 of Stimulation and Completion of experiment

Secondary outcomes

  1. Berg Balance Scale, BBS

    Used for clinical assessment of balance function. The assessment includes 14 items, with each item scored from 0 to 4 points, resulting in a total score of 56 points. The scores are divided into three groups: 0-20, 21-40, and 41-56, which correspond to three activity states: wheelchair use, assisted walking, and independent walking. If the total score is less than 40 points, it indicates a risk of falling.

    Time frame: Baseline、Week 1 of Stimulation and Completion of experiment

  2. 36-Item Short Form Health Survey,SF-36

    Including 36 items divided into 8 dimensions: physiological function, role-physical, bodily pain, general health, vitality, social function, role-emotional, and mental health. These dimensions belong to two major categories: physical health and mental health. The final score for each dimension ranges from 0 (lowest) to 100 (highest), with higher scores indicating better quality of life.

    Time frame: Baseline、Week 1 of Stimulation and Completion of experiment

  3. 6-Min Walk Test, 6MWT

    The walking speed test, which measures the distance a patient can walk in 6 minutes, reflects the overall functional status of the cardiorespiratory and musculoskeletal systems in daily activities.

    Time frame: Baseline、Week 1 of Stimulation and Completion of experiment

  4. Kinematic Assessment

    The three-dimensional motion capture system is used to obtain kinematic records (gait temporal parameters, spatial parameters; hip, knee, and ankle joint angles) of patients during walking. The system's infrared cameras capture human kinematics by using infrared reflective markers placed on anatomical landmarks. High-definition cameras are used to capture patients' timing photographic images, which demonstrate the dynamics of patient movement through superimposed consecutive snapshots.

    Time frame: Baseline、Week 1 of Stimulation and Completion of experiment

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07907952
Responsible party
Yang Lu (Attending Physician of Beijing Tsinghua Changgung Hospital, Beijing Tsinghua Chang Gung Hospital) — Principal investigator
First posted
Oct 30, 2026
Start date
Dec 1, 2024
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Oct 30, 2026

Study contacts

Yang Lu, MD
Contact
yanglu@btch.edu.cn
+8656119530
Yang Lu
principal investigator · Beijing Tsinghua Chang Gung Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion